Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sjögren’s syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial
Thomas Dörner, Martin Kaul, Antónia Szántó, Jui-Cheng Tseng, Athena Papas, Ilona Pylvaenaeinen and 10 more
- Rank
- 47 of 1,011
- Percentile
- top 4.7%
- Where
- Annals of the Rheumatic Diseases, 2023
- Citations
- 60
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.